论文部分内容阅读
目的探讨复方福尔可定口服溶液的临床疗效和安全性。方法采用随机、对照、开放的方法,将120例急性上呼吸道感染、急性气管及支气管炎、轻型肺炎伴有中度咳嗽、咳痰、鼻塞、流涕症状的患儿分为两组。治疗组60例应用复方福尔可定口服溶液;对照组60例使用肺力咳合剂,其他抗感染及对症治疗用药相同。在治疗前及治疗后3d、5d对呼吸道单个状症及症状综合评分并记录不良反应,比较两组疗效和安全性。结果两组治疗前后比较疗效显著,但治疗组咳嗽、咳痰、鼻塞、流涕各指标疗效及综合疗效评价与对照组比较差异显著;治疗组对药物接受程度更好(P<0.05);两组不良反应少且轻微。结论复方福尔可定口服溶液是一种安全有效的化痰止咳药,且依从性较好。
Objective To investigate the clinical efficacy and safety of Fufang Ke Er oral solution. Methods A total of 120 children with acute upper respiratory tract infection, acute trachea and bronchitis, mild pneumonia with moderate cough, expectoration, nasal congestion and runny nose were divided into two groups according to a randomized, controlled and open method. The treatment group, 60 cases of Fufang Er oral solution; control group, 60 cases of lung cough mixture, the other anti-infection and symptomatic treatment with the same medication. Before treatment and after treatment 3d, 5d of respiratory ailments and symptoms comprehensive score and record adverse reactions, the efficacy and safety of the two groups were compared. Results The curative effect of the two groups was significant before and after treatment, but the curative effect of cough, sputum, nasal obstruction and runny nose in the treatment group and the evaluation of comprehensive curative effect were significantly different from those in the control group. The treatment group received better drug acceptance (P <0.05) Adverse reactions were mild and mild. Conclusion Fufang Er oral solution is a safe and effective Huatan antitussive, and compliance is better.